Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Charite University, Berlin, Germany
University Hospital Tuebingen
Medical Centre, Ludwigshafen, Germany
Medical University Innsbruck
Information provided by:
ProteoSys AG
ClinicalTrials.gov Identifier:
NCT00400894
First received: November 16, 2006
Last updated: February 2, 2007
Last verified: February 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2006
  Primary Completion Date: No date given
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):